|
INGELYRVIGVNNDLLNR
|
|
|
|
SHYEKLKGSPEDNEQKQL
|
|
|
|
CEKMRIRIIDWDRLTHND
|
|
|
|
FDICTLFMEVMLPREELY
|
|
|
|
VGAAGVGKSALTIQL
|
|
|
|
YGRKKRRQRRRIQYRKAVKATLVLLPLLGITYMLFF
|
|
|
|
FITC-, Biotin-, 5-Fam-, Dansyl, TMR(TAMRA), Dnp
|
FITC-, Biotin-, 5-Fam-等熒光標(biāo)記多肽合成
|
|
|
SEVKQLIKAIQLTYN
|
|
|
|
RGIVEQCCTSICSLY
|
|
|
|
FPDFFTRVALYVDWI
|
|
|
|
SHLVEALYLVC
|
|
|
|
RINSAKDDAAGLQIA
|
|
|
|
CLMGFPVLVV
|
|
|
|
MASTOPARAN X
|
|
72093-22-2
|
|
Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys
|
|
|
|
MELITTIN
|
蜂毒素
|
20449-79-0
|
|
SARS-CoV-2 Spike Glycoprotein BA.2-Omicron
|
|
|
|
SARS-CoV-2 Spike Glycoprotein D614G
|
|
|
|
SARS-CoV-2 M
|
|
|
|
SARS-CoV-2 Nucleoprotein, 222-230
|
|
|
|
SARS-CoV-2 Y14
|
|
|
|
SARS-CoV-2 ORF10
|
|
|
|
SARS-CoV-2 Spike Glycoprotein-Omicron-90% purity
|
|
|
|
SARS-CoV-2 Nucleoprotein, 219-227
|
|
|
|
SARS-CoV-2 E
|
|
|
|
SARS-CoV-2 Spike Glycoprotein B.1.617.2-Delta
|
|
|
|
GNLIALSLGLTPNFKSNF
|
|
|
|
Biotin-HDG(Bpa)WWHSMTMW
|
|
|
|
QAKLASFITQYSTGQVSV
|
|
|
|
VAGVSICSTMTNRQF
|
|
|
|
SITMWFSLA
|
|
|
|
C-(PEG)-(PEG)-(PEG)-(PEG)-IVPAS
|
|
|
|
TFNGKDDLLCGAATAGNM
|
|
|
|
CSFEEAREVFENTERTTEFWK
|
|
|
|
EDIVLTLTLFEDREMIEE
|
|
|
|
GNRYHLRCYMYQARDLAA
|
|
|
|
AGKLEMTLEIVAESEHEE
|
|
|
|
CQRLSTGSRINSAKDDAAGLQIA
|
|
|
|
GILGFVFTL
|
|
|
|
KYRYLFKQVASSTGFCDQ
|
|
|
|
MPVQIRVKLWFGLSVDEK
|
|
|
|
GEGVAYRGRLLLSLETKL
|
|
|
|
GGDKRPAATKKAGQAKKK
|
|
|
|
ALYLVCGERGFFYTP
|
|
|
|
Ac-vsireavsqvlsgydwsgsgsygrkkrrqrrr-Amide
|
|
|
|
Ac-ILMTLFLFISCNNSGKDGNTSANSAGGGS-(K-Biotin)
|
|
|
|
SARS-CoV-2 Nucleoprotein, 299-315
|
|
|
|
SARS-CoV-2 ORF6
|
|
|
|
SARS-CoV-2 Spike Glycoprotein-90%
|
|
|
|
Biotin-CNNLDSKVGGNYLYRGPGLQSYGFQPTNGVGYQC
|
|
|
|
KRQLVETRQITKHVAQIL
|
|
|
|
VLRGKLQLVGTAAML
|
|
|
|
EETEDPSVIGEFKGLFKI
|
|
|
|
ILWRRFRWAIILFIILFI
|
|
|
|
AAYDIEVNTR
|
|
|
|
RIRVLSFKTGIISLCKAH
|
|
|
|
(HNPA)-ISQAVHAAFAEINEAGR-(K-biotin)
|
|
|
|
Biotin-I-Bpa-FPIRWLVNKTTKPLFLWYDLIGLITYPILLLIN
|
|
|
|
PRRARSVASQSIIAY
|
|
|
|
MAPIDHTTM
|
|
|
|
GTQCLAMGWGRVGAH
|
|
|
|
LVCGERGFFYTPKTR
|
|
|
|
RLTYAYFAGGDAGDA
|
|
|
|
SARS-CoV-2 ORF8
|
|
|
|
SARS-CoV-2 ORF3a
|
|
|
|
WMNKCHAGHLNGVYYQGGTYSKA
|
|
|
|
VDVCGMFTN
|
|
|
|
GDATTAYANSVFNIC
|
|
|
|
TRGSQPSGELLASFELIQ
|
|
|
|
KLPLDARPER
|
|
|
|
TKEQISRNSKALEEKYVA
|
|
|
|
CTNPLADC
|
|
|
|
SARS-CoV-2 ORF9B
|
|
|
|
SARS-CoV-2 Nucleoprotein, 138-146
|
|
|
|
SARS-CoV-2 Spike Glycoprotein B.1.1.529-Omicron
|
|
|
|
EILVNEEDIKGYRVTSTG
|
|
|
|
HAEDALIIANADFIFKEW
|
|
|
|
SPNQTSLYFCASTHD
|
|
|
|
PLFNETLFFNLFDSPGEL
|
|
|
|
SQSLSLTCSVTGYSI
|
|
|
|
ALQKGRTFNL
|
|
|
|
SARS-CoV-2 ORF7b
|
|
|
|
HCoV-229E Spike Glycoprotein
|
|
|
|
WWDLKPGAPKPKANQQKQ
|
|
|
|
NLGRAVFQAKKRVLEPLG
|
|
|
|
TMR-Asp-Arg-Val-Tyr-Ile
|
|
|
|
Cy5-AQVNSCLLLPNLLGCGDDK-(K-SMCC)
|
|
|
|
ALASVLLALLLSGAA
|
|
|
|
(azidoaceticacid)-PVHLELASMTNMELMSSIVHQV(K-(Peg)2-Biotin)
|
|
|
|
SRVVHLYRNGKDQDG
|
|
|
|
VVCTFVFGYLLPLLLICFCYAYGRKKRRQRRR
|
|
|
|
DNQSITKAAACYSLH
|
|
|
|
SARS-CoV-2 Spike Glycoprotein RBD B.1.617.2-Delta
|
|
|
|
SARS-CoV-2 Spike Glycoprotein
|
|
|
|
SARS-CoV-2 Nucleoprotein, 159-167
|
|
|
|
HCoV-OC43 Spike glycoprotein
|
|
|
|
SARS-CoV-2 ORF7a
|
|
|
|
SARS-CoV-2 Spike Glycoprotein RBD N501Y
|
|
|
|
SARS-CoV-2 N
|
|
|
|
SARS-CoV-2 Nucleoprotein, 292-308
|
|
|